1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
oa
IGRT has limited clinical value due to lack of accurate tumor delineation
Rent:
Rent this article for
Access full text Article
/content/aapm/journal/medphys/40/4/10.1118/1.4789492
1.
1. M. van Herk, “Errors and margins in radiotherapy,” Semin. Radiat. Oncol. 14, 5264 (2004).
http://dx.doi.org/10.1053/j.semradonc.2003.10.003
2.
2. D. A. Jaffray, “Image-guided radiation therapy: From concept to practice,” Semin. Radiat. Oncol. 17, 243244 (2007).
http://dx.doi.org/10.1016/j.semradonc.2007.08.001
3.
3. A. Bujold, T. Craig, D. Jaffray, and L. A. Dawson, “Image-guided radiotherapy: Has it influenced patient outcomes?,” Semin. Radiat. Oncol. 22, 5061 (2012).
http://dx.doi.org/10.1016/j.semradonc.2011.09.001
4.
4. C. F. Njeh, “Tumor delineation: The weakest link in the search for accuracy in radiotherapy,” J. Med. Phys. 33, 136140 (2008).
http://dx.doi.org/10.4103/0971-6203.44472
5.
5. C. Rasch, R. Steenbakkers, and M. van Herk, “Target definition in prostate, head and neck,” Semin. Radiat. Oncol. 15, 136145 (2005).
http://dx.doi.org/10.1016/j.semradonc.2005.01.005
6.
6. E. Weiss and C. F. Hess, “The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences,” Strahlenther. Onkol. 179, 2130 (2003).
http://dx.doi.org/10.1007/s00066-003-0976-5
7.
7. F. Buettner, S. L. Gulliford, S. Webb, M. R. Sydes, D. P. Dearnaley, and M. Partridge, “Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: An analysis of data from the MRC RT01 trial (ISRCTN 47772397),” Phys. Med. Biol. 54, 65356548 (2009).
http://dx.doi.org/10.1088/0031-9155/54/21/006
8.
8. X. A. Li, A. Tai, D. W. Arthur, T. A. Buchholz, S. Macdonald, L. B. Marks, J. M. Moran, L. J. Pierce, R. Rabinovitch, A. Taghian, F. Vicini, W. Woodward, and J. R. White, “Variability of target and normal structure delineation for breast cancer radiotherapy: An RTOG multi-institutional and multiobserver study,” Int. J. Radiat. Oncol., Biol., Phys. 73, 944951 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2008.10.034
9.
9. A. C. Riegel, A. M. Berson, S. Destian, T. Ng, L. B. Tena, R. J. Mitnick, and P. S. Wong, “Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion,” Int. J. Radiat. Oncol., Biol., Phys. 65, 726732 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2006.01.014
10.
10. M. J. Zelefsky, M. Kollmeier, B. Cox, A. Fidaleo, D. Sperling, X. Pei, B. Carver, J. Coleman, M. Lovelock, and M. Hunt, “Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. 84, 125129 (2012).
http://dx.doi.org/10.1016/j.ijrobp.2011.11.047
11.
11. H. P. Soares et al., “Evaluation of new treatments in radiation oncology: Are they better than standard treatments?,” J. Am. Med. Assoc. 293, 970978 (2005).
http://dx.doi.org/10.1001/jama.293.8.970
12.
12. M. Van Herk, “Will IGRT live up to its promise?,” Acta Oncol. 47, 11861187 (2008).
http://dx.doi.org/10.1080/02841860802279717
13.
13. B. Engels, G. Soete, D. Verellen, and G. Storme, “Conformal arc radiotherapy for prostate cancer: Increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers,” Int. J. Radiat. Oncol., Biol., Phys. 74(2), 388391 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2008.08.007
14.
14. G. S. Mageras and J. Mechalakos, “Planning in the IGRT context: Closing the loop,” Semin. Radiat. Oncol. 17, 268277 (2007).
http://dx.doi.org/10.1016/j.semradonc.2007.06.002
15.
15. S. H. Benedict et al., “Stereotactic body radiation therapy: The report of AAPM Task Group 101,” Med. Phys. 37, 40784101 (2010).
http://dx.doi.org/10.1118/1.3438081
16.
16. K. E. Rusthoven et al., “Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases,” J. Clin. Oncol. 27, 15721578 (2009).
http://dx.doi.org/10.1200/JCO.2008.19.6329
17.
17. R. Timmerman et al., “Stereotactic body radiation therapy for inoperable early stage lung cancer,” J. Am. Med. Assoc. 303, 10701076 (2010).
http://dx.doi.org/10.1001/jama.2010.261
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/40/4/10.1118/1.4789492
Loading
/content/aapm/journal/medphys/40/4/10.1118/1.4789492
Loading

Data & Media loading...

Loading

Article metrics loading...

/content/aapm/journal/medphys/40/4/10.1118/1.4789492
2013-03-06
2014-12-27

Abstract

There is no abstract available for this article.

Loading

Full text loading...

/deliver/fulltext/aapm/journal/medphys/40/4/1.4789492.html;jsessionid=1l2y71nho5tfz.x-aip-live-06?itemId=/content/aapm/journal/medphys/40/4/10.1118/1.4789492&mimeType=html&fmt=ahah&containerItemId=content/aapm/journal/medphys
true
true
This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: IGRT has limited clinical value due to lack of accurate tumor delineation
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/40/4/10.1118/1.4789492
10.1118/1.4789492
SEARCH_EXPAND_ITEM